Your heart valves regulate blood flow but when advanced valve disease causes problems, valve replacement surgery may be necessary. Surgeons look to two trials on new approaches to improve on patient outcomes.
Stay informed about heart, vascular and thoracic topics in this continuation of The Beating Edge blog from our Heart & Vascular Institute, which is ranked No. 1 in heart care in the nation by U.S. News & World Report.
People with diabetes are more likely to develop heart disease. Clouding this issue, the FDA recently issued a warning that statin therapy may be associated with an increased risk of developing diabetes. What gives?
A Cleveland Clinic patient with a slowed heartbeat is the third in the nation to receive the device as part of an international, multicenter clinical trial testing its safety and efficacy for FDA approval.
Statin therapy is a popular first-line treatment to lower LDL cholesterol and reduce the risk of heart attacks and death. While most people tolerate statins quite well, occasionally side effects can occur. Dr. Michael Rocco explains what to watch out for.
At Cleveland Clinic, we know our surgeons’ skills and experience -- inside and outside the operating room -- are important to our patients’ ability to recover speedily from surgery. A recent study supports that perspective.
Explore the secrets to heart health using imagery, video and animation. Learn the reality behind common myths about diet, exercise, risk factors, smoking and your heart.
Swiss pharmaceutical company Actelion gets FDA approval on new drug for use in treating Group 1 pulmonary arterial hypertension. Compared with earlier drugs, macitentan caused side effects in fewer patients.
From fish oil to a “heart disease gene,” misconceptions about heart health abound. The truth is most Americans don’t know what steps they should take to keep their heart healthy. Find out what’s myth vs. fact to proactively take steps to prevent heart disease.
The discovery of how the carrier of so-called “good” cholesterol becomes dysfunctional represents the first step toward creating new tests and treatments for cardiovascular disease.
An experimental device that had shown promise and raised hopes for controlling stubbornly and dangerously high blood pressure is not effective, a new study involving Cleveland Clinic cardiologists and patients shows.